Company Overview
Apixio is an AI-powered healthcare analytics company specializing in risk adjustment for Medicare Advantage plans. The company uses machine learning to analyze clinical documentation — identifying HCC (Hierarchical Condition Category) codes that support accurate risk adjustment and ensuring MA plans are appropriately compensated for the actual health complexity of their enrolled populations.
Apixio's platform automates the chart review process — traditionally a manual, expensive, and error-prone workflow — using AI and NLP to scan clinical documentation and flag coding opportunities and compliance risks. The company serves major Medicare Advantage plans and health systems seeking to improve risk adjustment accuracy without proportionally increasing administrative costs.
Products & Platform
Market Position
Apixio's AI-first approach and NLP capabilities for unstructured clinical data differentiate it from traditional chart review companies. For senior care providers, Apixio's risk adjustment data is significant because accurate HCC coding determines MA payment rates — directly affecting how much MA plans pay post-acute providers for care delivered to enrolled members.
Key Data & Metrics
| Metric | Detail |
|---|---|
| Total Funding | ~$100M raised |
| Founded | 2009 |
| Headquarters | San Mateo, CA |
| Technology | AI-powered NLP for clinical document analysis |
Recent News & Developments
How Dorthea Uses This Technology Category
Dorthea's AI co-pilot helps families understand how platforms like Apixio affect the quality and accountability of senior care facilities and home care agencies they are evaluating. Our free guidance helps families ask the right questions.